Home  >  Products  >  BBS9 (Bardet-Biedl syndrome 9 ) Blocking Peptide (the N terminal of BBS9)(100ug)
BBS9 (Bardet-Biedl syndrome 9 ) Blocking Peptide (the N terminal of BBS9)(100ug)

BBS9 (Bardet-Biedl syndrome 9 ) Blocking Peptide (the N terminal of BBS9)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BBS9 Antibody (ARP65858_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP65858
Size: 100ug
Weight: 95kDa
Gene: 27241
Format: Lyophilized powder
Target: This gene is downregulated by parathyroid hormone in osteoblastic cells, and therefore, is thought to be involved in parathyroid hormone action in bones. The exact function of this gene has not yet been determined. Alternatively spliced transcript variants encoding different isoforms have been identified.
Alternative names: B1; C18; D1; MGC118917; PTHB1